Funding
Series D · Healthtech

Leo Cancer Care raises $65m Series D

Yu Galaxy and Eventide Asset Management participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Leo Cancer Care raised $65 million in Series D financing on July 8, with participation from Yu Galaxy and Eventide Asset Management. The company develops systems for cancer treatment in an upright position.

Funding history

Series D · This round$65M

Sources

  1. Leo Cancer Careprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related